Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?

CONCLUSION: While the middle aged brain does not seem to impair drug and cell therapies, in a real clinical practice involving older post-stroke patients, successful regenerative therapies would have to be carried out for a much longer time. PMID: 28093317 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28093317?dopt=Abstract

Source: Experimental Gerontology - January 12, 2017 Category: Geriatrics Authors: Sandu RE, Balseanu A, Bogdan C, Slevin M, Petcu E, Popa-Wagner A Tags: Exp Gerontol Source Type: research